Novavax to Present at the 28th Annual Piper Jaffray Healthcare Conference
November 22 2016 - 4:05PM
GAITHERSBURG, Md., Nov. 22, 2016
(GLOBE NEWSWIRE) -- Novavax, Inc., (Nasdaq:NVAX) today announced
Stanley C Erck, President and Chief Executive Officer, will present
at the 28th Annual Piper Jaffray Healthcare Conference.
Conference details are as
follows:
Date: Tuesday, November 29,
2016
Time: 3:30 pm U.S. Eastern Time
Location: New York Palace Hotel, New York, New York
Live webcast: novavax.com, "Investors"/ "Events"
A replay of the presentation will
also be accessible under the "Investors/Events" section of the
Novavax website at novavax.com.
About
Novavax
Novavax, Inc. (Nasdaq:NVAX) is a
clinical-stage vaccine company committed to delivering novel
products to prevent a broad range of infectious diseases. Our
recombinant nanoparticles and Matrix-M(TM) adjuvant technology are
the foundation for groundbreaking innovation that improves global
health through safe and effective vaccines. Additional information
about Novavax is available on the Company's
website, novavax.com.
Contact:
Novavax, Inc.
Barclay A. Phillips
SVP, Chief Financial Officer and Treasurer
Andrea N. Flynn, Ph.D.
Associate Director, Investor Relations
ir@novavax.com
240-268-2000
Russo Partners, LLC
David Schull
Todd Davenport, Ph.D.
david.schull@russopartnersllc.com
todd.davenport@russopartnersllc.com
212-845-4271
This
announcement is distributed by Nasdaq Corporate Solutions on behalf
of Nasdaq Corporate Solutions clients.
The issuer of this announcement warrants that they are solely
responsible for the content, accuracy and originality of the
information contained therein.
Source: Novavax, Inc. via Globenewswire
Novavax (NASDAQ:NVAX)
Historical Stock Chart
From Mar 2024 to Apr 2024
Novavax (NASDAQ:NVAX)
Historical Stock Chart
From Apr 2023 to Apr 2024